Discover Telos Corporation's Q3 2025 earnings: record revenue growth, Xacta.ai launch, and raised outlook for 2026.

Revenue -- Reported at $3.7 million for the three months ended September 30, 2025, up from $2.3 million in the same period in 2024; the increase was due to a $1.5 million rise in license revenues, ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...

Recognizing the increasing need for climate-responsive infrastructure investment, the IMF introduced the Climate-Public ...